Moreover, combination treatment showed downregulation of the expression of inflammation-related genes that are involved in tumor inflammation, such as Gremlin (GREM1), IL-1β, IL-4, NF-κB, and prostaglandin-endoperoxide synthase 2 (PTGS2), tumor nitric oxide level [163]. Here, GREM1 is linked to neoplasm.